Filter by audience:

Neurologists & Headache specialists
Other: primary care physicians, internists, and other healthcare providers involved in the management of patients with migraine
Basic scientists involved in the study of traumatic brain injury, headache, and allodynia
Cardiologists

Oral sessions summaries


Headache

Rimegepant 75 mg Provides Early and Sustained Relief of Migraine with a Single Oral Dose: Results from 3 Phase 3 Clinical Trials

Jelena Pavlovic, MD, PhD

Expert commentary by Stephanie J. Nahas, MD, MSEd, FAHS, FAAN

AHSAM 2020 - Oral session
Published on September 11, 2020

View
Award lecture

Wolff Award: Cognitive Networks Disarrangement in Patients with Migraine Predicts Cutaneous Allodynia

Antonio Russo, MD, PhD

AHSAM 2020 - Oral session
Published on July 17, 2020

View
Award lecture

Early Career Award: Alterations in Functional Connectivity during Different Phases of the Triggered Migraine Attack

Nazia Karsan, MRCP PhD

AHSAM 2020 - Oral session
Published on July 17, 2020

View
Award lecture

Solomon Award Lecture: Observations 2020 - 'Teaching Headache'

R. Allan Purdy, MD, FAHS

AHSAM 2020 - Oral session
Published on July 17, 2020

View
Award lecture

Graham Award: Practical Approach to Eye Pain and Photophobia

Kathleen B. Digre, MD, FAHS

AHSAM 2020 - Oral session
Published on July 17, 2020

View
COVID-19

Headache & COVID-19: A Short-term Challenge with Long-term Insights

Patricia Pozo-Rosich, MD, PhD

AHSAM 2020 - Oral session
Published on July 17, 2020

View
COVID-19

COVID-19 and Headache: The New York Experience

Matthew S. Robbins, MD, FAHS

AHSAM 2020 - Oral session
Published on July 17, 2020

View
COVID-19

Migraine Care in the Era of COVID‐19: Clinical Pearls and Plea to Insurers

Christina Szperka, MD, MSCE, FAHS

AHSAM 2020 - Oral session
Published on July 17, 2020

View
Chronic Migraine

A Pregnancy Outcomes Following Exposure to OnabotulinumtoxinA Update – 29 Years of Safety Observation

Mitchell Brin, MD

Expert commentary by Carrie Dougherty, MD, FAHS

AHSAM 2020 - Oral session
Published on July 30, 2020

View
Idiopathic Intracranial Hypertension

Retrospective Review of the Use of Anti-CGRP Monoclonal Antibodies to Treat Headaches in Patients with Idiopathic Intracranial Hypertension

Lindsay Frerichs, MD

Expert commentary by Deborah I. Friedman, MD, MPH, FAAN, FAHS

AHSAM 2020 - Oral session
Published on July 30, 2020

View
Migraine

The Role of Cerebellar CGRP in Migraine-like Behavior

Mengya Wang, Master

Expert commentary by Amynah Pradhan, PhD

AHSAM 2020 - Oral session
Published on July 23, 2020

View
Migraine

Characteristics of Individuals with Migraine Who Are Eligible for Novel CGRP Monoclonal Antibodies: Results of the OVERCOME Study

Richard B. Lipton, MD

Expert commentary by Carrie Dougherty, MD, FAHS

AHSAM 2020 - Oral session
Published on July 30, 2020

View
Migraine

Multiple, Once-daily, Oral Doses of 170 Mg Atogepant for 28 Days Are Safe and Well Tolerated with No Clinically Significant Effect on Alanine Aminotransferase in Healthy Adults

K. Chris Min, MD, PhD

Expert commentary by Jessica Ailani, MD

AHSAM 2020 - Oral session
Published on September 3, 2020

View
Migraine

Eptinezumab Demonstrated Migraine Preventive Efficacy on Day 1 After Dosing: Closed Testing Analysis from PROMISE-1 and PROMISE-2

David W Dodick

Expert commentary by Jessica Ailani, MD

AHSAM 2020 - Oral session
Published on September 3, 2020

View
Migraine

Improved Functionality, Satisfaction, and Global Impression of Change with Ubrogepant for the Acute Treatment of Migraine in Triptan Insufficient Responders

Richard Lipton, MD

Expert commentary by Randolph W. Evans, MD

AHSAM 2020 - Oral session
Published on September 11, 2020

View
Migraine

Efficacy and Safety of AXS-07 (MoSEIC™ Meloxicam/Rizatriptan) in the Acute Treatment of Migraine: Results from the MOMENTUM Phase 3 Trial

Cedric O'Gorman, MD

Expert commentary by Randolph W. Evans, MD

AHSAM 2020 - Oral session
Published on September 11, 2020

View
Migraine

A Real-World Comparison of Erenumab and Galcanezumab in a Tertiary Headache Center

Alise Pham, DO

Expert commentary by Jessica Ailani, MD

AHSAM 2020 - Oral session
Published on September 17, 2020 | NEW

View
Pediatrics

Improving Headache Management in the Pediatric Emergency Department

Jessica L. Hauser, MD, PhD

AHSAM 2020 - Oral session
Published on July 30, 2020

View
Pediatrics

Childhood and Adolescent Migraine Prevention [CHAMP] Trial: The 3-year Follow-up Survey Results

Scott W. Powers, PhD, ABPP, FAHS

Expert commentary by Marcy Yonker, MD, FAHS

AHSAM 2020 - Oral session
Published on July 30, 2020

View
Post-traumatic Headache

Exploring Naturally Occurring Clinical Subgroups of Post-traumatic Headache

Tommy Chan, MBBS

Expert commentary by Nada Hindiyeh, MD

AHSAM 2020 - Oral session
Published on July 23, 2020 

View
Post-traumatic Headache

Effects of Pre-injury Migraine Frequency on Post-traumatic Headache Recovery in the General Adult Population: The Toronto Concussion Study

Laura K. Langer, MSc

Expert commentary by Nada Hindiyeh, MD

AHSAM 2020 - Oral session
Published on July 23, 2020 

View
Post-traumatic Headache

Mild TBI induces long-lasting sensitization to pain in mice

Anne-Sophie Wattiez, PhD

Expert commentary by Andrew Russo, PhD

AHSAM 2020 - Oral session
Published on August 27, 2020

View